Category Archives: Pradaxa

Featured Stories

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Pradaxa®, Other New Blood Thinners Can Triple Bleeding Risks in ACS Patients, Study Finds

A study of new blood thinners, including Pradaxa®, has found that these novel drugs pose an elevated bleeding risk that cancels out their benefits in patients with Acute Coronary Syndrome (ACS).  According to a report from MedPage Today, the study … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Study Finds New Blood Thinner Hasn’t Had Much Effect on Treatment of Atrial Fibrillation

A new Pradaxa study conducted by U.S. researchers has found that Pradaxa hasn’t really changed the way doctors treat atrial fibrillation, its approved indication.  According to a report from the UPI, the same study also found that a growing number … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Study Sees Higher Bleeding, Clot Risk after Atrial Fibrillation Ablation

A study published in February reported that patients who took Pradaxa (dabigatran) following radiofrequency ablation to treat atrial fibrillation experienced more bleeding and blood clots compared to people who were treated with warfarin post-procedure.  The authors of the study, published … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Bleeding Lawsuits To Proceed “Expeditiously,” Federal Judge Promises

A total of 78 Pradaxa bleeding lawsuits are now pending in the multidistrict litigation in U.S. District Court, Southern District of Illinois.  According to a report from The Madison Record, U.S. District Judge David Herndon has scheduled the Pradaxa litigation’s … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa, Other Dangerous Drugs Make it to Market Thanks to Quick FDA Approvals

A new study has questioned the Food and Drug Adminstration’s (FDA) process for approving new prescription drugs, especially after the agency allowed a trio of products to reach the market without serious questions about their safety being answered, including the … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Bleeding Lawsuit MDL Established in District of Southern Illinois

Lawsuits alleging the maker of Pradaxa failed to adequately warning users of its association with life-threatening, uncontrolled bleeding have been consolidated in a multidistrict litigation in U.S. District Court, Southern District of Illinois.  All Pradaxa injury lawsuits filed in federal … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Bid to Dismiss Pradaxa Bleeding Lawsuits Rejected

A federal judge in Illinois has denied Boehringer Ingelheim Pharmaceuticals motion to dismiss Pradaxa bleeding lawsuits.  The decision by Judge David Herndon in U.S. District Court, Southern District of Illinois, comes as Pradaxa plaintiffs throughout the country wait to hear … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation.  According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

64 More Plavix Patients File Suit Over Bleeding Side Effects

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa.  Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because … Continue reading

Posted in Pharmaceuticals, Pradaxa |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.